Boehringer Ingelheim India Private Limited, a active private limited company, was established on 11 December 2003 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24230MH2003PTC143499. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹6.47 Cr and a paid-up capital of ₹6.47 Cr.
It upholds a compliant status. Employing 744 professional, Its leadership includes Sandipkumar Rameshchandra Agrawal (Director), Sanjay Srivastava (Director), Shriya Mandar Oak (Director). Past directors included Paul Barlow Stewart, Sharad Tyagi, Harshada Manohar Rane. Its latest AGM occurred on 20 September 2024, with the balance sheet filed on 31 March 2024. It is based at Unit No. 202, 2Nd Floor, Godrej 2, Pirojshah Nagar,, Eastern Express Highway, Vikhroli East, Mumbai, Mumbai, Maharashtra, 400079.
U24230MH2003PTC143499
143499
11 December 2003
₹6.47 Cr
₹6.47 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Boehringer Ingelheim India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sandipkumar Rameshchandra Agrawal | Director | 11 Oct 2017 | Current |
| Sanjay Srivastava | Director | 21 Nov 2022 | Current |
| Shriya Mandar Oak | Director | 23 May 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Mar 2011 | Past |
| Pramod Abcsdd | Managing Director | 25 Feb 2021 | Past |
| Pramod Abcsdd | Director | 01 Oct 2008 | Past |
| Pramod Abcsdd | Director | 22 Sep 2021 | Past |
| Pramod Abcsdd | Additional Director | 29 Nov 2017 | Past |
| Pramod Abcsdd | Director | 19 Nov 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Boehringer Ingelheim India Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.83% decrease. The company also saw a substantial fall in profitability, with a 34.88% decrease in profit. The company's net worth dipped by a decrease of 8.09%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Boehringer Ingelheim India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Boehringer Ingelheim India has a workforce of 744 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Boehringer Ingelheim India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Boehringer Ingelheim India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Boehringer Ingelheim India Private Limited last Annual general meeting of members was held on 20 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Shriya Mandar Oak was appointed as a Director was appointed as a Director on 23 May 2024 & has been associated with this company since 1 year 6 months . was documented.
Boehringer Ingelheim India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on Sanjay Srivastava was appointed as a Director was appointed as a Director on 21 Nov 2022 & has been associated with this company since 3 years 7 days . was documented.
Sandipkumar Rameshchandra Agrawal was appointed as a Director was appointed as a Director on 11 Oct 2017 & has been associated with this company since 8 years 1 month . was recorded as a recent event.
Boehringer Ingelheim India Private Limited was registered on 11 Dec 2003 with Roc Mumbai & aged 21 years 11 months as per MCA records. was recorded as a recent event.
The CIN of Boehringer Ingelheim India Private Limited is U24230MH2003PTC143499.
Boehringer Ingelheim India Private Limited is headquartered at Unit No. 202, 2Nd Floor, Godrej 2, Pirojshah Nagar,, Eastern Express Highway, Vikhroli East, Mumbai, Mumbai, Maharashtra, 400079.
Boehringer Ingelheim India Private Limited was incorporated on 11 December 2003.
The current directors of Boehringer Ingelheim India Private Limited are
The primary industry of Boehringer Ingelheim India Private Limited is Trade.
Boehringer Ingelheim India Private Limited is unlisted.
The authorized capital of Boehringer Ingelheim India Private Limited is ₹6.47 Cr, and the paid-up capital is ₹6.47 Cr.
The compliance status of Boehringer Ingelheim India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX